| # | Drug | Count |
|---|---|---|
| 0 | PANCRELIPASE | 30 |
| 1 | ERGOCALCIFEROL | 8 |
| 2 | OMEPRAZOLE MAGNESIUM | 8 |
| 3 | ASPIRIN | 6 |
| 4 | OMEPRAZOLE | 6 |
| 5 | SPIRONOLACTONE | 6 |
| 6 | ASPIRIN 325 MG | 5 |
| 7 | ASPIRIN 81 MG | 5 |
| 8 | HYDROXYCHLOROQUINE | 5 |
| 9 | METFORMIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BORIC ACID | 1 | 0.0028 |
| 1 | PLATINUM | 1 | 0.0019 |
| 2 | PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE | 1 | 0.0015 |
| 3 | VALERIAN | 1 | 0.0014 |
| 4 | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | 1 | 0.0011 |
| 5 | PANCRELIPASE | 30 | 0.0008 |
| 6 | CHLORZOXAZONE | 1 | 0.0008 |
| 7 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 3 | 0.0007 |
| 8 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 2 | 0.0007 |
| 9 | VANDETANIB | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 12 |
| 1 | Benzodiazepine [EPC] | 11 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 |
| 3 | Provitamin D2 Compound [EPC] | 8 |
| 4 | Vitamin C [EPC] | 7 |
| 5 | Aldosterone Antagonist [EPC] | 6 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 6 |
| 7 | Proton Pump Inhibitor [EPC] | 6 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 5 |
| 9 | Corticosteroid [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | mu-Opioid Receptor Agonist [EPC] | 1 | 0.0003 |
| 2 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 3 | Photoenhancer [EPC] | 1 | 0.0003 |
| 4 | GLP-2 Analog [EPC] | 3 | 0.0002 |
| 5 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 7 | Cannabinoid [EPC] | 1 | 0.0001 |
| 8 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |